Cargando…
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases
Exhaled nitric oxide (NO) production, upregulated by inflammatory cytokines and mediators in central and peripheral airways, can be easily and non-invasively detected in exhaled air in asthma and other respiratory conditions as a promising tool for disease monitoring. The American Thoracic Society a...
Autores principales: | Ragnoli, Beatrice, Radaeli, Alessandro, Pochetti, Patrizia, Kette, Stefano, Morjaria, Jaymin, Malerba, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395178/ https://www.ncbi.nlm.nih.gov/pubmed/37538344 http://dx.doi.org/10.1177/20406223231190480 |
Ejemplares similares
-
Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014) -
Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities
por: Malerba, Mario, et al.
Publicado: (2014) -
Pneumothorax in hospitalized COVID-19 patients with severe respiratory failure: Risk factors and outcome
por: Ragnoli, B., et al.
Publicado: (2023)